SCHEMBL872853

SCHEMBL872853

C/C=C(/C)C(=O)OCC/C=C\CC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.39
NR1I2 O75469 2/20 0.39
PTGS2 P35354 2/20 0.39
PGR P06401 1/20 0.39
PDE4D Q08499 1/20 0.39
ALDH1A1 P00352 6/20 0.37
CYP19A1 P11511 4/20 0.37
PPARG P37231 3/20 0.37
OXER1 Q8TDS5 3/20 0.37
MAPT P10636 3/20 0.37
RXRA P19793 2/20 0.37
FFAR1 O14842 2/20 0.37
CYP3A4 P08684 2/20 0.37
ALOX15 P16050 2/20 0.37
HSD17B10 Q99714 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
TSHR P16473 1/20 0.37
LPAR2 Q9HBW0 3/20 0.36
LPAR3 Q9UBY5 3/20 0.36
LPAR1 Q92633 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL406228 1.00 ADORA3 (0.39) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL3383981 1.00 ADORA3 (0.39) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL4631039 1.00 ADORA3 (0.39) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL1532457 1.00 ADORA3 (0.39) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL406229 1.00 ADORA3 (0.39) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL1771437 1.00 ADORA3 (0.39) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL9933295 1.00 ADORA3 (0.39) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL21485374 1.00 ADORA3 (0.39) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL21485375 1.00 ADORA3 (0.39) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL1868201 0.93 ALDH1A1 (0.37) ADORA3NR1I2PTGS2PGRPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4356894-A1 SUSTAINABLE PRODUCT WITH MALODORS Beiersdorf AG (DE) 2024-04-24 EP claimed
EP-4435080-B1 A PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE PROCTER & GAMBLE (US) 2025-08-20 EP disclosed
EP-3955900-B1 POLYMERIC CAPSULES PROCTER & GAMBLE (US) 2025-07-23 EP disclosed
EP-4435080-A1 A PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE The Procter & Gamble Company (US) 2024-09-25 EP disclosed
EP-3596192-B1 BENEFIT AGENT CONTAINING DELIVERY PARTICLE SLURRIES PROCTER & GAMBLE (US) 2024-05-15 EP disclosed
EP-4356894-A1 SUSTAINABLE PRODUCT WITH MALODORS Beiersdorf AG (DE) 2024-04-24 EP disclosed
EP-3664900-B1 PHOTOSENSITIVE MICROCAPSULES PROCTER & GAMBLE INT OPERATIONS SA (CH) 2023-08-23 EP disclosed
CN-116606692-A Dendrobium flower fragrance extract and preparation method, application and detection method thereof 广西壮族自治区亚热带作物研究所(广西亚热带农产品加工研究所) 2023-08-18 CN disclosed
US-10006151-B2 Polyurethane fiber TORAY OPELONTEX CO., LTD. (JP) 2018-06-26 US disclosed
EP-2947185-B1 POLYURETHANE FIBER AND ITS USE TORAY OPELONTEX CO LTD (JP) 2018-02-28 EP disclosed
WO-2012039516-A1 DEODORANT COMPOSITION FOR SULFIDES TAKASAGO INTERNATIONAL CORPORATION (JP) 2012-03-29 WO disclosed
US-20090087401-A1 DEODORANT COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2009-04-02 US disclosed
US-20080085251-A1 even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; RESONAC CORPORATION (JP) 2008-04-10 US disclosed
EP-1827370-A1 HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR Showa Denko K.K. (JP) 2007-09-05 EP disclosed
US-20060165622-A1 Deodorant composition TAKASAGO INTERNATIONAL CORPORATION (JP) 2006-07-27 US disclosed
WO-2006068276-A1 HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR SHOWA DENKO K.K. (JP) 2006-06-29 WO disclosed
EP-1561476-A1 DEODORANT COMPOSITION Takasago International Corporation (JP) 2005-08-10 EP disclosed
EP-0112394-B1 PROCESS FOR PREPARING ANGELIC ACID OR ITS ESTER TORAY INDUSTRIES, INC. (JP) 1989-11-02 EP disclosed
US-4613680-A ISOMERIZATION TORAY INDUSTRIES, INC. (JP) 1986-09-23 US disclosed
EP-0112394-A1 PROCESS FOR PREPARING ANGELIC ACID OR ITS ESTER TORAY INDUSTRIES, INC. (JP) 1984-07-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085251-A1 even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; TST, CYSLTR1, CYSLTR2 ADORA3 949/4885NR1I2 117/4885PTGS2 815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.